Investment Firm
Overview
CRISPR Therapeutics is focused on the development of transformative medicines using its proprietary CRISPR/Cas9 gene-editing platform.
Apr 29, 2015
Series A
Highlights
Location
Social
Participant Investors
5
CRISPR Therapeutics raised $35000000 on 2015-04-29 in Series A
CRISPR Therapeutics is focused on the development of transformative medicines using its proprietary CRISPR/Cas9 gene-editing platform.
Company Funding History
6
Announcment Date | Transaction Name | Number Of Investors | Lead Investor | Money Raised |
---|---|---|---|---|
Dec 14, 2020 | Grant - CRISPR Therapeutics | 1 | - | undefined |
Feb 13, 2024 | Post-IPO Equity - CRISPR Therapeutics | 2 | - | 280.0M |
Jun 24, 2016 | Series B - CRISPR Therapeutics | 4 | - | 38.0M |
Apr 24, 2014 | Series A - CRISPR Therapeutics | 1 | - | 25.0M |
Recent Activity
There is no recent news or activity for this profile.